Ledlie E M, Mynors L S, Draper G J, Gorbach P D
Br Med J. 1970 Oct 24;4(5729):195-200. doi: 10.1136/bmj.4.5729.195.
Hospital records and other data relating to Wilms's tumour were analysed to elucidate both thenatural history of the disease and the effects of treatment, with special reference to actinomycin D. The age of maximum incidence was about 18 months; left-sided tumours were significantly more common than right-sided ones.Prognosis was related to stage of the disease at the initial operation and to the occurrence of metastasis. The three-year survival rate for cases having a nephrectomy was 35%; no child who did not have a nephrectomy survived.Recurrence of the tumour was observed in two-thirds of the cases, almost always within two years of the initial treatment, irrespective of the child's age. The three-year survival rate for this group was 11%.The effects of radiotherapy and chemotherapy are considered in detail. Very little improvement in survival rate could be ascribed to actinomycin D. The reasons for this and for the variations found in earlier reports on selected cases are possibly the addition of other components of treatment and differences in drug regimens. The findings suggest the need for controlled clinical trials.
对与肾母细胞瘤相关的医院记录及其他数据进行了分析,以阐明该疾病的自然史及治疗效果,特别提及放线菌素D。发病高峰年龄约为18个月;左侧肿瘤比右侧肿瘤明显更常见。预后与初次手术时疾病的分期及转移的发生情况有关。接受肾切除术的病例三年生存率为35%;未接受肾切除术的儿童无一存活。三分之二的病例出现肿瘤复发,几乎总是在初始治疗后的两年内,与患儿年龄无关。该组的三年生存率为11%。详细考虑了放疗和化疗的效果。生存率的提高很少能归因于放线菌素D。出现这种情况以及早期对特定病例报告中发现差异的原因,可能是治疗中添加了其他成分以及药物方案的不同。研究结果表明需要进行对照临床试验。